CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Open-market sale Chief Executive Officer sold 69,832 shares at $5.33 ($372,267)
- 4 Open-market sale SVP, Chief Legal Officer sold 13,578 shares at $5.33 ($72,383)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 13,500 shares at $5.23 ($70,574)
- 144 Insider Sale of Securities
- 4 Grant or award Chief Financial Officer acquired 133,595 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 365,422 shares (grant or award)
- 4 Grant or award SVP, Chief Legal Officer acquired 113,949 shares (grant or award)
- 4 Planned sale Chief Executive Officer sold 25,000 shares at $5.31 ($132,740)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 15,000 shares at $4.74 ($71,168)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Executive Officer sold 249 shares at $5.49 ($1,366)
Page 6 of 66 · 1,318 filings